
Vali oma silt
näidatakse otse viaalilDapagliflozin (Forxiga)
Medication
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
Lühidalt
Dapagliflozin (Forxiga) arvudes
Põhinäitajad meie leksikonist. Lohista punkti mööda kõverat, et näha, kui palju jääb pärast ühte annust arvutuslikult alles.
Täielik leksikoni artikkelHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~12.9 hours
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about12.9hours
- Class
- SGLT2 inhibitorgliflozin, selective
- Use
- Oral1x daily
- Sizes
- 10 mg1 size in the shop
What studies show
All 6 sources in the lexicon- McMurray et al., NEJM, 2019
Dapagliflozin and cardiovascular outcomes in type 2 diabetes (DECLARE-TIMI 58) (opens in a new tab)
Wiviott et al., NEJM, 2019Euglycemic diabetic ketoacidosis as a complication of SGLT2 inhibition (opens in a new tab)
Peters et al., Diabetes Care, 2015
Arvustused
Mida kliendid ütlevad
Ainult päris tellimused, milles oli Dapagliflozin (Forxiga).
Kõik arvustusedDapagliflozin (Forxiga) jaoks pole veel laborianalüüsi. Hääleta selle pooltLase ise testida, meie maksame pooleKõik laborianalüüsid
Teadmised
Kõik teemal Dapagliflozin (Forxiga)
Üksikasjalik teave tuleb peagi.
How does dapagliflozin work?
It blocks the transporter SGLT2 in the kidney, which brings filtered sugar back into the blood. The sugar then leaves with the urine without insulin being needed. Breakdown runs mainly via the enzyme UGT1A9 to an inactive metabolite.
Does it help without diabetes?
In the trials on heart failure and chronic kidney disease the effect was similar with and without diabetes. With reduced pumping the risk of worsening or cardiac death fell by 26 percent.
What did the kidney trial show?
Among 4,304 participants 9.2 percent on dapagliflozin and 14.5 percent on placebo had an event (halved kidney function, kidney failure or death). 19 had to be treated to prevent one. The trial was therefore stopped early.
What is euglycaemic ketoacidosis?
Acidosis from ketones with nearly normal blood sugar. Because sugar does not rise much, it was recognised late in a case series. The authors advise checking ketones in case of nausea, vomiting or malaise. In the large diabetes trial it occurred in 0.3 versus 0.1 percent.
Does it lower heart attacks and strokes?
Not clearly in the diabetes trial with 17,160 patients: 8.8 versus 9.4 percent major cardiovascular events. Hospital stays for heart failure and kidney events did fall clearly.
Which side effects are known?
Serious genital infections or those leading to a stop occurred in 0.9 versus 0.1 percent, ketoacidosis in 0.3 versus 0.1 percent. In the heart failure trials volume depletion, kidney problems and low blood sugar were not more common than on placebo.
Seotud
Seotud tooted
Telmisartan
Ravimid · Süda ja veresooned Süda ja veresooned
2 suurust
Laboris testitud
Ivermectin
Ravimid · Magu ja maks Magu ja maks
1 suurus
Fenbendazol
Ravimid · Magu ja maks Magu ja maks
1 suurus
Prednisone
Ravimid · Magu ja maks Magu ja maks
1 suurus
Dapagliflozin (Forxiga)